logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울서부지방법원 2017.04.28 2016고단988
의료법위반
Text

Defendant

A 25 million won, Defendant B 20 million won, and Defendant C 15 million won, respectively.

Reasons

Punishment of the crime

1. Defendant A is a doctor who operates a family department A in Dobong-gu Seoul Metropolitan Government G.

No medical person, founder of a medical institution, or person working for a medical institution shall receive money, goods, benefits, labor, entertainment, or other economic benefits provided by a person who has obtained a product license of a drug or a person who has filed a product notification for the purpose of sales promotion, such as adoption of a drug or inducement for prescription

Nevertheless, the Defendant, upon receiving a proposal from H to provide economic benefits, such as cash, by prescribing soft drugs, which are the business employees of the pharmaceutical company (hereinafter “malking”), was to comply with the proposal. On April 201, the Defendant received cash amounting to KRW 9,00,000, which was provided for the purpose of promoting the sales of drugs from the above H from the above medical clinic at the above clinic around the above clinic around April 201, and received the cash amounting to KRW 80,590,000 in total over 33 times from around that time until June 2014, as shown in attached Table 1.

As a result, the Defendant received money equivalent to KRW 80,590,000, which was provided for the purpose of sales promotion such as adoption of medicines and inducement of prescription.

2. Defendant B, from November 1, 1989, is a medical institution employee who works as a clinical sergeant and office staff at the K physician operated by the J physician of Dobong-gu Seoul Metropolitan Government from around November 1, 1989, and is involved in the adoption, etc. of medicine of the above Council member.

A. On February 2010, the Defendant, in breach of trust, committed an illegal solicitation to the effect that he/she would put in a drug code and offer the price according to the face value of the week so that the pharmaceutical products can be prescribed by the above member of the Council. On February 2, 2010, the Defendant agreed with the above H and received KRW 12,50,000 in cash in return for the price from H around June 2010.

arrow